R&D and cash runway
Disconnected budgets, purchase commitments and vendor invoices make it difficult to see how much funding remains available for each programme.
Your science is moving forward. Your operations should keep up. We help biotech, pharmaceutical and medical device businesses bring finance, purchasing and operational data together, from research funding to commercial growth, without confusing an ERP with a laboratory or quality system.
An emerging biotech managing runway does not need the same starting scope as a manufacturer preparing a launch. The useful question is not ‘which modules can we buy?’ but ‘which decisions are we struggling to make?’
Disconnected budgets, purchase commitments and vendor invoices make it difficult to see how much funding remains available for each programme.
CRO invoices arrive after activity takes place. Finance needs a defensible accrual process based on contracts, milestones and operational evidence, not just invoices received.
CMOs, CDMOs and logistics partners hold critical data. Inventory, batch and cost visibility suffer when every partner sends a different spreadsheet.
New entities, currencies, products and distribution channels introduce reporting and control requirements that an early-stage accounting setup may not support.
We start with the processes you need to control. NetSuite capabilities, additional modules and integrations are selected against that scope; specialised clinical, laboratory and quality systems keep their own responsibilities.
Structure budgets and actual spend by programme, study, department or project. Agree cost allocation and reporting definitions before configuring dashboards.
Design a reviewed workflow for CRO estimates, purchase orders, milestones and reconciliation. Automation supports the process; finance still owns the assumptions and sign-off.
Connect purchase requests, approvals, orders and supplier bills so teams can see committed as well as invoiced spend, with roles appropriate to their responsibilities.
Where relevant, configure lot tracking, expiry information and inventory across locations. Define quality-release and traceability boundaries with your quality team and external partners.
Assess OneWorld for subsidiaries, currencies and consolidation. Build reporting that helps leadership compare programmes and understand cash, not merely close the books.
Assess SyncBIT for connecting partner and specialist systems. Define the source of truth, access, error handling and reconciliation for each data flow before choosing the connection method.
Imagine a finance lead preparing a board update: the programme budget is in one file, CRO estimates in another, and purchasing commitments in email. Installing software alone will not make those figures agree. The first step is shared definitions, ownership and a repeatable reconciliation process.
Our starting point is a conversation with Finance, Operations, Quality and IT about the decisions they need to make. We map what belongs in NetSuite, what should stay in specialist systems, and which interfaces and controls are genuinely necessary.
Then we define a first scope that can be tested with representative data: a programme-cost view, an approval chain, a month-end accrual or a partner stock feed. Broader rollout follows agreed acceptance criteria, not a promise that every process will fit out of the box.
“Better ERP design starts with clear ownership of the data, not a longer feature list.”
BIT combines NetSuite implementation, integration and ongoing optimisation. Your quality and regulatory specialists remain essential: an ERP does not automatically make a business GxP-compliant, validated or audit-ready.
Map the growth stage, intended use, reporting priorities, stakeholders and data owners before deciding the ERP scope.
Separate finance and operational workflows from clinical, laboratory and quality responsibilities. Assess integrations and validation needs together.
Agree migration checks, permissions, approval paths and acceptance tests with the people who will run the processes.
Plan training, change control, interface monitoring and managed support so the setup can evolve as programmes and markets change.
It can be, when reporting, purchasing control or multi-entity needs have outgrown the current setup. Start with the business case and a proportionate scope; a complex implementation is not automatically the right first step.
Project accounting and configured reporting can organise study costs and commitments. CRO accruals require reliable activity data, agreed estimates and review workflows; requirements may call for integrations or additional configuration.
No. ERP primarily connects business operations and finance. Laboratory, quality and clinical systems have specialist responsibilities; integrations should move only the data needed for agreed business processes.
No. Applicability depends on intended use and the relevant records and processes. Your quality and regulatory experts must assess validation, access, audit trails, electronic signatures, procedures and change control. Software alone is not a compliance guarantee.
Yes, a phased approach can be appropriate. Plan data structures and integration boundaries early, then assess inventory, distribution and revenue requirements as commercialisation approaches. Modules and scope depend on your operating model.
Tell us where your programmes stand, which figures are hard to trust and which systems need to connect. We can discuss a realistic NetSuite scope and the responsibilities around it.